Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-01-26 @ 5:42 PM
Study NCT ID:
NCT01307618
Status:
TERMINATED
Last Update Posted:
2016-10-24
First Post:
2011-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2011-02580
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None